CompoAtlas

GATTILIER

Food supplement declared in France, declaration No 2023-11-816, decision dated 17 November 2023

GATTILIER is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
HELIOS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes

Declaration 136607, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Vitex agnus-castus L.FruitPoudre (de plantes séchées ou broyées)96 mg

Other ingredients

maltodextrine, gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé en cas de cancer hormono-dépendant, de tumeur hypophysaire à prolactine, ou d’antécédents de troubles hypophysaires.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line